GB Patent

GB9605074D0 — Dosage forms and uses

Assigned to Chirotech Technology Ltd · Expires 1996-05-08 · 30y expired

What this patent protects

A pharmaceutical dosage form comprises, in a portion thereof, substantially single enantiomer (R)-verapamil and, in another, separate, portion thereof, substantially single enantiomer (S)-verapamil, wherein, in use, the different enantiomers are released at different rates from t…

USPTO Abstract

A pharmaceutical dosage form comprises, in a portion thereof, substantially single enantiomer (R)-verapamil and, in another, separate, portion thereof, substantially single enantiomer (S)-verapamil, wherein, in use, the different enantiomers are released at different rates from the dosage form.

Drugs covered by this patent

Patent Metadata

Patent number: GB9605074D0
Jurisdiction: GB
Classification: —
Expires: 1996-05-08
Drug substance claim: No
Drug product claim: No
Assignee: Chirotech Technology Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.